Virtual Medicinal Product (VMP) - Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Methylprednisolone 80mg/2ml / Lidocaine 20mg/2ml (1%) suspension for injection vials Start Date 21-06-2004 End Date
Previous Name Previous Name Methylprednisolone 40mg/ml / Lidocaine 10mg/ml injection 2ml vials Start Date 01-12-2003 End Date 20-06-2004
Abbreviated Name Abbreviated Name Methylprednisolone 80mg / Lidocaine 20mg/2ml (1%) inj vials Start Date 01-05-2009
Previous Abbreviated Name Methylpred 80mg/Lidocaine 20mg/2ml(1%)susp for inj vl Previous Start Date 13-09-2004 Previous End Date 30-04-2009

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
2
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intraarticular, Periarticular, Intrabursal
Form
Suspension for injection
Ontology Form/Route
suspensioninjection.intraarticular, suspensioninjection.periarticular, suspensioninjection.intrabursal
Name Basis
Other

Codes

ATC Code
H02BX01
BNF Start Date End Date
Current BNF 10010202 Start Date 04-04-2022 End Date
Previous BNF 10010202 Start Date 15-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
36034511000001106 29-10-2018
325397005 02-12-2002 28-10-2018

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Lidocaine hydrochloride Based on Ingredient Substance 10 mg 1 ml
Methylprednisolone acetate Based on Ingredient Substance 40 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 706 Part VIIIA Category C
10 vial